Leading Indian drug makers Ranbaxy Laboratories Ltd and Cipla Ltd have submitted bids to acquire the generic drugs business, estimated to be worth $6 billion, of German pharma major Merck KGaA.
Click the following link http://ww4.6URL.com/16VE to read the complete article.
